Table 3 Laboratory Findings of Patients Infected With COVID-19 on Admission to Hospital
Normal range | Median (IQR) | P Valuea | |||
|---|---|---|---|---|---|
Total (N = 42) | Anal swab test positive (n = 6) | Anal swab test positive (n = 36) | |||
Leukocyte count, × 109/L | 3.5 ~ 9.5 | 5.2(3.9 ~ 6.2) | 5.0(3.6 ~ 6.6) | 5.3(4.1 ~ 6.3) | 0.820 |
Lymphocyte count, ×109/L | 0.8 ~ 4 | 1.3(0.9 ~ 1.8) | 1.8(0.6 ~ 2.3) | 1.2(1.0 ~ 1.6) | 0.539 |
lymphocyte percentage, % | 20 ~ 40 | 26.9(20.4 ~ 33.1) | 33.4(17.6 ~ 36.0) | 26.2(20.1 ~ 32.7) | 0.408 |
Haemoglobin, g/L | 130 ~ 175 | 142.5(131.0 ~ 155.5) | 147(134.3 ~ 160.0) | 139(131.0 ~ 154.8) | 0.516 |
Platelet count, ×109/L | 125 ~ 350 | 181(145.8 ~ 231.0) | 234.5(127.5 ~ 305.3) | 179.5(146.3 ~ 223.8) | 0.493 |
ESR, mm/1 h | 0 ~ 15 | 25(11.3 ~ 44.8) | 18(7.1 ~ 36.0) | 26(12.8 ~ 45.3) | 0.210 |
C-reactive protein, mg/L | 0 ~ 6 | 11.3(2.4 ~ 35.2) | 9.3(1.7 ~ 33.3) | 11.3(2.4 ~ 36.6) | 0.471 |
Procalcitonin, μg/L | 0.0 ~ 0.5 | 0.05(0.03 ~ 0.05) | 0.05(0.03 ~ 0.05) | 0.05(0.03 ~ 0.05) | 0.661 |
Total bilirubin, μmol/L | 3.42 ~ 8.2 | 7.2(4.7 ~ 8.7) | 6.5(2.8 ~ 7.5) | 7.5(4.8 ~ 8.9) | 0.159 |
Alanine aminotransferase, U/L | 0 ~ 40 | 25.5(14.0 ~ 40.0) | 30(7.3 ~ 57.5) | 24(15.0 ~ 37.3) | 0.793 |
Aspartate aminotransferase, U/L | 5 ~ 49 | 27.5(22.0 ~ 35.5) | 27.5(22.0 ~ 43.8) | 27.5(22.0 ~ 35.0) | 0.739 |
Albumin, g/L | 60 ~ 85 | 43.7(40.6 ~ 45.9) | 46.1(43.2 ~ 48.2) | 42.7(40.5 ~ 45.5) | 0.075 |
Creatine kinase, U/L | 26 ~ 196 | 91.5(68.8 ~ 133.3) | 108.5(85.5 ~ 195.5) | 90(61.3 ~ 126.3) | 0.281 |
Lactate dehydrogenase, U/L | 109 ~ 245 | 244.5(202.5 ~ 308.5) | 240(193 ~ 290) | 244.5(202.8 ~ 309.5) | 0.586 |
Creatinine, μmol/L | 59 ~ 104 | 61.0(51.5 ~ 70.9) | 60.9(52.0 ~ 64.5) | 62.7(51.2 ~ 71.2) | 0.713 |
Blood urea nitrogen, mmol/L | 1.43 ~ 8.2 | 3.3(2.5 ~ 5.0) | 4.7(4.0 ~ 5.3) | 3.1(1.5 ~ 7.7) | 0.040 |
Glucose, mmol/L | 3.89 ~ 6.11 | 5.6(5.2 ~ 6.8) | 5.0(4.7 ~ 6.6) | 5.7(5.3 ~ 6.9) | 0.123 |
D-dimers, mg/L | 0 ~ 0.55 | 0.3(0.2 ~ 0.4) | 0.3(0.2 ~ 0.5) | 0.3(0.2 ~ 0.4) | 1.000 |
Prothrombin time, s | 9 ~ 14 | 11.4(11.0 ~ 11.9) | 11.0(10.8 ~ 12.9) | 11.4(11.0 ~ 11.9) | 0.586 |
APTT, s | 20 ~ 40 | 26.1(23.7 ~ 28.6) | 26.2(23.1 ~ 30.6) | 26.1(24.5 ~ 27.6) | 0.958 |
Thrombin time, s | 14 ~ 21 | 16.4(15.8 ~ 17.6) | 16.9(15.8 ~ 18.0) | 16.3(15.8 ~ 17.5) | 0.562 |
Fibrinogen, g/L | 2 ~ 4 | 3.4(2.9 ~ 4.5) | 3.1(2.4 ~ 4.5) | 3.5(3.1 ~ 4.5) | 0.314 |
Endotoxin, pg/mL | <10 | 90.4(8.3 ~ 176.0) | 31.4(4.4 ~ 388.9) | 100.7(8.5 ~ 176.0) | 0.576 |
SpO2, % | 91.9 ~ 99.9 | 98(97 ~ 99) | 98(98 ~ 100) | 98(97 ~ 99) | 0.265 |
PaCO2, mmHg | 35 ~ 45 | 37.0(34 ~ 41) | 36.0(33.4 ~ 42.7) | 37.0(34.1 ~ 41.0) | 0.933 |
PaO2:FIO2, mmHg | 400 ~ 500 | 388.1(330.2 ~ 487.1) | 486.2(409.5 ~ 680.1) | 381.0(318.6 ~ 467.8) | 0.040 |
BNP, ng/L | 0 ~ 125 | 50(50 ~ 58.3) | 50(50 ~ 50) | 50(50 ~ 82.3) | 0.600 |
Troponin I, μg/L | 0 ~ 1.68 | 0.8(0.6 ~ 0.9) | 0.8(0.6 ~ 0.9) | 0.8(0.6 ~ 0.9) | 0.741 |
Fecal occult blood test, positive | 4(14.3%) | 2(40%) | 2(8.7%) | 0.135 | |